A tighter look at the products that matter most to Edwards Lifesciences, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 4 structured disruption concepts across the current product set.
Transcatheter structural-heart devices
2 conceptsEdwards' SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA systems are transcatheter heart-valve platforms used for selected aortic stenosis and failed-bioprosthetic valve indications.
Advanced hemodynamic monitoring
2 conceptsHemoSphere is an advanced monitoring platform for hemodynamic and tissue-oxygenation parameters, with compatibility across cuffs, sensors, and catheters and decision-support features such as hypotension prediction when paired with compatible Acumen products.
Paper trail
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Edwards Lifesciences · annual report
Primary source for company overview, 2024 sales, gross profit, R&D intensity, business lines, and TAVR/TMTT growth discussion.
Reviewed 2026-06-02
Edwards Lifesciences · product page
Primary product source for SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA indications and positioning.
Reviewed 2026-06-02
Edwards Lifesciences · product page
Primary product source for HemoSphere monitoring capabilities, sensor and catheter compatibility, and decision-support positioning.
Reviewed 2026-06-02
CompaniesMarketCap · market data
Market-data source for approximate May 2026 market capitalization used in the registry metrics.
Reviewed 2026-06-02
StockAnalysis · market data
Market-data source for current valuation snapshot, including P/E ratio and revenue context.
Reviewed 2026-06-02